Unknown

Dataset Information

0

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenstrom's Macroglobulinemia.


ABSTRACT: The use of Bruton Tyrosine Kinase (BTK) inhibitors in Waldenström's Macroglobulinemia (WM) is evolving. Ibrutinib, a first-generation BTK inhibitor, is currently approved for use in frontline and relapsed/refractory disease. Second-generation BTK inhibitors are being used and studied to improve clinical outcomes and/or safety profile. Zanubrutinib, one such second-generation inhibitor, was recently approved in treatment-naive and refractory/relapsed patients. Here, we review the use of BTK inhibitors in WM in front-line and refractory or relapsed settings. We also highlight common adverse events, the emergence of BTK inhibitors resistance, and future directions of their use.

SUBMITTER: Ababneh O 

PROVIDER: S-EPMC9358782 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström's Macroglobulinemia.

Ababneh Obada O   Abushukair Hassan H   Qarqash Aref A   Syaj Sebawe S   Al Hadidi Samer S  

Clinical hematology international 20220523 1-2


The use of Bruton Tyrosine Kinase (BTK) inhibitors in Waldenström's Macroglobulinemia (WM) is evolving. Ibrutinib, a first-generation BTK inhibitor, is currently approved for use in frontline and relapsed/refractory disease. Second-generation BTK inhibitors are being used and studied to improve clinical outcomes and/or safety profile. Zanubrutinib, one such second-generation inhibitor, was recently approved in treatment-naive and refractory/relapsed patients. Here, we review the use of BTK inhib  ...[more]

Similar Datasets

| S-EPMC10107762 | biostudies-literature
| S-EPMC9883164 | biostudies-literature
| S-EPMC10100639 | biostudies-literature
| S-EPMC5010774 | biostudies-literature
| S-EPMC7083517 | biostudies-literature
| S-EPMC7727553 | biostudies-literature
| S-EPMC8783859 | biostudies-literature
| S-EPMC7874350 | biostudies-literature
| S-EPMC9898035 | biostudies-literature